Novo Holdings A/S's Form 4 filing
Edgewise Therapeutics, Inc. (EWTX) · filed Sep 16, 2022
- Accession no.
- 0001209191-22-050258
- Filed
- Sep 16, 2022
- Trade date
- Sep 14, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $5.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Novo Holdings A/SCIK 0001388325 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | COMMON STOCK | PPurchaseAcquired | +484,496 | $10.32F1 | +$4,999,998.72 | 6,071,703 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents a purchase from the underwriters in the Issuer's public offering.
Referenced by the price of 1 transaction in Table I.